- Home
- DRRX
DRRX
DURECT Corporation
as 12-18-2024 9:36am EST
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | CUPERTINO |
| Market Cap: | 44.4M | IPO Year: | 2000 |
| Target Price: | $5.00 | AVG Volume (30 days): | 124.3K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.48 - $1.88 | Next Earning Date: | 11-13-2024 |
| Revenue: | $8,594,000 | Revenue Growth: | -6.53% |
| Revenue Growth (this year): | 54.32% | Revenue Growth (next year): | -72.74% |
Latest DURECT Corporation News
DRRX Breaking Stock News: Dive into DRRX Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
Durect (DRRX) Upgraded to Buy: Here's What You Should Know
Zacks
20 days ago
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
PR Newswire
23 days ago
DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million
Thomson Reuters StreetEvents
a month ago
Q3 2024 DURECT Corp Earnings Call
GuruFocus.com
a month ago
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
Zacks
a month ago
Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
Associated Press Finance
a month ago
Durect: Q3 Earnings Snapshot
PR Newswire
a month ago
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
Compare DRRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DRRX DURECT Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.